“…In particular, in ATM, distinct mutations have been found that cause different human malignancies, including lung cancer, breast cancer, colon cancer, lymphocytic leukemia, pancreatic cancer, and head and neck cancer, among others (Ding et al, 2008;Goldgar et al, 2011;Guarini et al, 2012;Roberts et al, 2012;Seshagiri et al, 2012) (see poster). Homozygous loss-of-function mutations or deletion of ATR or Chk1 have not yet been reported; however, there are sporadic studies that show mutations in ATR or Chk1 in certain cancer types (Kim et al, 2007;Lewis et al, 2007;Liu et al, 2008;Menoyo et al, 2001;Zighelboim et al, 2009) (see poster), suggesting that the ATRChk1 axis cannot be generalized as a canonical tumor suppressor pathway.…”